News Daily News Study Questions Incremental Benefit of Beta-Blockers After Acute MI Michael O'Riordan September 21, 2017
News Daily News Debating the ARB/MI Paradox: Is It Real, or Is the Story Incomplete? Michael O'Riordan June 05, 2017
News Conference News ACC 2017 FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo Michael O'Riordan March 17, 2017
News Daily News Yet Another Set of Hypertension Guidelines Sow Confusion Surrounding BP Targets in Older Patients Michael O'Riordan January 17, 2017